104 related articles for article (PubMed ID: 38762015)
1. LncRNA DARS-AS1 in human cancers: A comprehensive review of its potency as a biomarker and therapeutic target.
Dang Q
Gene; 2024 May; 923():148566. PubMed ID: 38762015
[TBL] [Abstract][Full Text] [Related]
2. DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy.
Shu J; Xia K; Luo H; Wang Y
Int J Med Sci; 2024; 21(3):571-582. PubMed ID: 38322590
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
Huang K; Fan WS; Fu XY; Li YL; Meng YG
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2353-2359. PubMed ID: 30964159
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA DARS-AS1 Contributes to Prostate Cancer Progression Through Regulating the MicroRNA-628-5p/MTDH Axis.
Fan H; Hou J; Liu S; Xiao Z; Cui J
Cancer Manag Res; 2020; 12():8363-8377. PubMed ID: 32982430
[TBL] [Abstract][Full Text] [Related]
5. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
6. DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m
Shen W; Zhu M; Wang Q; Zhou X; Wang J; Wang T; Zhang J
RNA Biol; 2022 Jan; 19(1):751-763. PubMed ID: 35638109
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DARS-AS1 promotes tumor progression by directly suppressing PACT-mediated cellular stress.
Yang L; Lin K; Zhu L; Wang H; Teng S; Huang L; Zhou S; Zhang G; Lu ZJ; Wang D
Commun Biol; 2022 Aug; 5(1):822. PubMed ID: 35970927
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LncRNA DARS-AS1 Inhibits the Tumorigenesis of Cervical Cancer via Inhibition of IGF2BP3.
Zhu J; Han S
Onco Targets Ther; 2021; 14():1331-1340. PubMed ID: 33658798
[TBL] [Abstract][Full Text] [Related]
10. DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway.
Chen Y; Wu Q; Lin J; Wei J
Cancer Cell Int; 2020 Nov; 20(1):535. PubMed ID: 33292218
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of lncRNA DARS-AS1 accelerates tumor malignancy in cervical cancer by activating cGMP-PKG pathway.
Kong X; Wang JS; Yang H
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-11. PubMed ID: 33634536
[TBL] [Abstract][Full Text] [Related]
12. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
Li J; Li Y; Sun X; Wei L; Guan J; Fu L; Du J; Zhang X; Cheng M; Ma H; Jiang S; Zheng Q; Wang L
Mol Carcinog; 2024 Apr; 63(4):757-771. PubMed ID: 38289172
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
15. DARS-AS1 Knockdown Inhibits the Growth of Cervical Cancer Cells via Downregulating HMGB1 via Sponging miR-188-5p.
Zhu J; Han S
Technol Cancer Res Treat; 2020; 19():1533033820971669. PubMed ID: 33176595
[TBL] [Abstract][Full Text] [Related]
16. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
[TBL] [Abstract][Full Text] [Related]
17. lncRNA DARS-AS1 Modulates TSPAN1-Mediated ITGA2 Hypomethylation by Interaction with miR-194-5p Thus Promoting Ovarian Cancer Progression.
Li J; Gao H; Chen B; Li L; Wang Q; Gao Z
Stem Cells Int; 2022; 2022():4041550. PubMed ID: 36187230
[TBL] [Abstract][Full Text] [Related]
18. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis.
Du C; Han X; Zhang Y; Guo F; Yuan H; Wang F; Li M; Ning F; Wang W
Open Med (Wars); 2022; 17(1):2036-2045. PubMed ID: 36568518
[TBL] [Abstract][Full Text] [Related]
19. Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis.
Liu X; Zhang G; Yu T; He J; Liu J; Chai X; Zhao G; Yin D; Zhang C
Cancer Lett; 2022 Sep; 543():215781. PubMed ID: 35688263
[TBL] [Abstract][Full Text] [Related]
20. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
